​

02-10-2020  Bioharmony Therapeutics CEO discussing AMR and the need for novel antimicrobials.

​

https://www.youtube.com/watch?v=E4a7_DhnMvY&feature=share

​

​

​

09-04-2019  Our partnership with Boehringer Ingelheim to address AMR. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

09-04-2019   Bioharmony Therapeutics to present a pipeline overview at the ASM-ESCMID Conference 2019 in Boston.

​

08-01-2019   Bioharmony Therapeutics featured as Life Science Leaders Companies to Watch.

https://www.lifescienceleader.com/doc/companies-to-watch-bioharmony-therapeutics-0001

​

​

02-08-2019   Bioharmony Therapeutics to present a pipeline overview at the Superbugs & Superdrugs 2019 Conference in London on March 18th, 2019 

​

​

01-29-2019    Bioharmony Therapeutics to present a pipeline overview at the Phage Futures Conference in Washington, D.C on January 30th, 2019. 

​

01-16-2019 Bioworld featuring Bioharmony Therapeutics.

http://www.bioworld.com/report/BWT01162019Bioharmony.pdf

​

01-15-2019  Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections

https://www.businesswire.com/news/home/20190115005244/en/Bioharmony-Therapeutics-Boehringer-Ingelheim-Collaborate-Advance-Bacteriophage

​

​

07-19-2018   Chandra Ghose has been selected to be part of the Aspen Global Leadership Network as a Fellow of the Aspen Institute’s fourth class of Health Innovators Fellows.  

https://www.aspeninstitute.org/news/press-release/2018-Health-Innovators-Fellows/

​

​

03-15-2018  Healthcare finalist Bioharmony Therapeutics pitches at the 2017 Hello Tomorrow Challenge Finals in Paris on Oct 26-27th,  2017.

 https://www.youtube.com/watch?v=g1mckE_ehr8

​

 

02-20-2018  Bioharmony Therapeutics featured in French media

https://www.maddyness.com/innovation/2018/02/20/international-huit-startups-qui-veulent-et-qui-pourraient-bien-changer-le-monde/

​

12-18-2017   Accelerate NY Seed Fund Awards Bioharmony Therapeutics $100,000 to Develop a Lysin-based Treatment for Skin Infections Caused by Multi-drug Resistant Acinetobacter baumanii

https://www.businesswire.com/news/home/20171218005117/en/Accelerate-NY-Seed-Fund-Awards-Bioharmony-Therapeutics

​

​

12-17-2017  Bioharmony Therapeutics in the news.

https://www.newsday.com/business/startup-venture-capital-1.15466724

​

​

11-15-2017  Bioharmony Therapeutics wins second place at RESI Innovation Challenge in NYC.

 

​

10-20-2017  Bioharmony Therapeutics to present at the RESI New York 2017 in NYC  on November 15, 2017 .  Please come and see us pitch at the Innovation Challenge.

​

09-15-2017  Bioharmony Therapeutics to present at the 2017 Life Sciences Summit 2017 in NYC  on November 1-2, 2017 .  

​

09-05-2017  We are excited to announce that we have been selected as a Healthcare Track Finalist in the 2017 #HTChallenge! @HelloTomorrow has reviewed 3,000 applications, selected the TOP 500 deep tech startups from around the globe, and now has chosen 7 of the most innovative projects in the Healthcare sector- which includes us! You can meet us and hear us pitch at the #HTSummit in Paris to discover what we do!

​

​

06-01-2017  Bioharmony Therapeutics to present at the NY Life Science Innovation Showcase 2017 in NYC  on June 13, 2017.

​

05-01-2017  Bioharmony Therapeutics to present at the NewYorkBio Annual Conference in NYC  on May 10, 2017.

​

04-01-2017  Bioharmony Therapeutics to present at the ELabNYC Pitch Day in NYC on April 6, 2017.

​

01-01-2017  Bioharmony Therapeutics has been chosen to be part of The Bio & Health Entrepreneurship Lab NYC class of 2017.  

​